Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)

Toshiaki Mano

Amagasaki, JP 
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Amagasaki, JP 
OverviewLocationsClinical Research

Overview

Toshiaki Mano practices in Amagasaki, Japan. Mr. Mano is rated as a Distinguished expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Atrial Fibrillation, Angioplasty, and Cardiac Ablation.

His clinical research consists of co-authoring 250 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Amagasaki, Japan
Other Locations
Japan
Osaka, 5430035, Japan
Kurashiki, Japan
Inabaso, 6608511, Japan
Nishinomiya-hama, Japan
Saitama, Japan
Tsukuba, 3050044, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective, Multicenter, Single-arm Clinical Trial of Jetstream Atherectomy System for the Treatment of Japanese Patients With Symptomatic Occlusive Atherosclerotic Lesions in the Superficial Femoral and/ or Proximal Popliteal Arteries
A Prospective, Multicenter, Single-arm Clinical Trial of Jetstream Atherectomy System for the Treatment of Japanese Patients With Symptomatic Occlusive Atherosclerotic Lesions in the Superficial Femoral and/ or Proximal Popliteal Arteries
Enrollment Status: Completed
Publish Date: August 16, 2021
Intervention Type: Device
Study Phase: Not Applicable

250 Total Publications

Efficacy of Low-Voltage-Area Ablation Is Enhanced in Patients With Advanced Left Atrial Enlargement: A Subanalysis of the SUPPRESS-AF Trial.
Efficacy of Low-Voltage-Area Ablation Is Enhanced in Patients With Advanced Left Atrial Enlargement: A Subanalysis of the SUPPRESS-AF Trial.
Journal: Circulation. Arrhythmia and electrophysiology
Published: September 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mano's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 10 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile